Loading clinical trials...

COMPLETEDPhase 3NCT01816139

Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women

The primary objective of this study is to compare the efficacy of WC3011 with placebo vaginal gel in postmenopausal women for the relief of vaginal dryness caused by vaginal atrophy as measured by sel...

Lead sponsor: Warner Chilcott•48 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer Patients

NCT06900374 · Vaginal Dryness, Breast Cancer, and more

COMPLETED

Validation of the DIVA (Day to Day Impact of Vaginal Aging) Questionnaire for Portuguese Women

NCT07250490 · Vulvovaginal Atrophy, Genital Disorder, and more

COMPLETEDNA

Combination of BTL-785F and HPM-6000UF Devices for Women's Intimate Wellness

NCT06846216 · Vulvovaginal Atrophy, Urinary Incontinence, and more

COMPLETEDPhase 4

Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women

NCT05586711 · Vulvovaginal Atrophy, Genitourinary Syndrome of Menopause

WITHDRAWNPhase 2

Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy

NCT02460302 · Atrophic Vaginitis, Menopause, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 9, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment576

Start dateJan 2013

Last updatedMay 9, 2022

Condition

Vulvovaginal Atrophy

Locations shown

Warner Chilcott Investigational Study Site

Huntsville, Alabama

Warner Chilcott Investigational Study Site

Mobile, Alabama

Warner Chilcott Investigational Study Site

Phoenix, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 9, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer Patients

Validation of the DIVA (Day to Day Impact of Vaginal Aging) Questionnaire for Portuguese Women

Combination of BTL-785F and HPM-6000UF Devices for Women's Intimate Wellness

Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women

Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy

Trial snapshot

Condition

Locations shown

For caregivers